Previous 10 | Next 10 |
home / stock / vptdf / vptdf news
(via TheNewswire) Toronto, Ontario / TheNewswire / September 5, 2018 - Ventripoint Diagnostics Ltd. (" Ventripoint " or the " Company ", TSXV:VPT) announces that it has closed the first tranche of its non-brokered private placement announced on August 15, 2018 (the " ...
(via TheNewswire) NOT FOR DISTRIBUTION TO UNITED STATES NEWSWIRE SERVICES OR FOR DISSEMINATION IN THE UNITED STATES Toronto, Ontario / TheNewswire / August 15, 2018 - Ventripoint Diagnostics Ltd. ("Ventripoint" or the "Company", TSXV:VPT) announces that it intends to c...
(via TheNewswire) Toronto, Ontario / TheNewswire / August 13, 2018 - Ventripoint Diagnostics Ltd. ("Ventripoint" or the "Company", TSXV:VPT) is pleased to present an update on its progress to provide better tools for cardiac analysis to cardiologists to improve diagnosis and...
(via TheNewswire) Toronto, Ontario / TheNewswire / August 8, 2018 - Ventripoint Diagnostics Ltd. ("Ventripoint" or the "Company", TSXV:VPT) is pleased to present an update on its progress to provide better tools for cardiac analysis to cardiologists to improve diagnosis and ...
(via TheNewswire) Toronto, Ontario / TheNewswire / August 1, 2018 - Ventripoint Diagnostics Ltd. ("Ventripoint" or the "Company", TSXV:VPT) is pleased to present an update on its progress to provide better tools for cardiac analysis to cardiologists to improve diagnosis and ...
(via TheNewswire) Toronto, Ontario / TheNewswire / July 17, 2018 - Ventripoint Diagnostics Ltd. ("Ventripoint" or the "Company", TSXV:VPT) is pleased to announce that the Mazankowski Alberta Heart Institute in Edmonton, Alberta has begun a study to evaluate the ability of ...
(via TheNewswire) Toronto, Ontario / TheNewswire / June 5 , 2018 - Ventripoint Diagnostics Ltd. ("Ventripoint" or the "Company", TSXV:VPT) is pleased to announce that MD Anderson Cancer Center in Houston, Texas has ordered the VMS+ complete heart analysis system for use i...
(via TheNewswire) Toronto, Ontario / TheNewswire / May 23 , 2018 - Ventripoint Diagnostics Ltd. ("Ventripoint" or the "Company", TSXV:VPT) is pleased to announce the appointment of Jim Graba, BSc, RDCS, FASE as Application Specialist and Chief Trainer. Jim will take the cli...
(via TheNewswire) Toronto, Ontario / TheNewswire / May 15, 2018 - Ventripoint Diagnostics Ltd. (" Ventripoint " or the " Company ") (TSXV:VPT) announces that it has received market clearance from the US Food and Drug Administration ("FDA") to sell its VMS+(TM) machine with the...
(via TheNewswire) Toronto, Ontario / TheNewswire / April 23, 2018 - Ventripoint Diagnostics Ltd. ("Ventripoint" or the "Company", TSXV:VPT) is pleased to announce that it exhibited at the 20 th annual Canadian Society of Echocardiography conference which was recently ...
News, Short Squeeze, Breakout and More Instantly...
VentriPoint Diagnostics Ltd Company Name:
VPTDF Stock Symbol:
OTCMKTS Market:
VentriPoint Diagnostics Ltd Website:
(TheNewswire) Toronto, Ontario – TheNewswire - July 2, 2024 – Ventripoint Diagnostics Ltd. (“ Ventripoint ” or the “ Corporation ”, ( TSXV:VPT) further to Ventripoint’s press release dated May 13, 2024 ...
(TheNewswire) Toronto, Ontario, June 27, 2024 – TheNewswire – Ventripoint Diagnostics Ltd. (“ Ventripoint ” or the “ Corporation ”, TSXV:VPT) announces that it will seek approval of TSX Venture Exchange ( ...
(TheNewswire) Toronto, Ontario – TheNewswire - June 24, 2024 – Ventripoint Diagnostics Ltd. ("Ventripoint" or the "Company"), (TSXV:VPT ) ; ( OTC:VPTDF) has been selected to present its AI-enhanced cardiac ultrasound technology, which ...